Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Horizon acquires U.S. rights to osteoarthritis drug
Seeking Alpha
Friday, October 17, 2014 - 10:54am
tags:
Horizon Pharma, Pennsaid, Nuvo Research, osteoarthritis of the knee
FDA facing huge pressure as Ebola worsens
Pharmaphorum
Friday, October 17, 2014 - 10:52am
tags:
FDA, ebola virus
GSK Expects Delayed Production Of Ebola Vaccine
Bidness Etc.
Friday, October 17, 2014 - 10:51am
tags:
GSK, ebola virus, vaccines
NewLink Continues Upward Trajectory On Ebola Scare
Bidness Etc.
Friday, October 17, 2014 - 10:18am
tags:
NewLink Genetics, ebola virus, VSV-EBOV, vaccines
Ethicon injoined from selling ultrasonic surgery device
Seeking Alpha
Friday, October 17, 2014 - 10:15am
tags:
Ethicon, Harmonic ACE +7, devices
Anoro Ellipta beats Spiriva HandiHaler in COPD trial
Seeking Alpha
Friday, October 17, 2014 - 10:12am
tags:
Anoro Ellipta, Spiriva HandiHaler, COPD, GSK, Boehringer Ingelheim
Roche, Merck extend immunotherapy fight to breast cancer
Yahoo/Reuters
Friday, October 17, 2014 - 10:08am
tags:
Roche, Merck, breast cancer, MPDL3280A, Keytruda
Quote of the Week: AbbVie’s About Face and Management Credibility
WSJ Pharmalot
Friday, October 17, 2014 - 10:07am
tags:
AbbVie, Shire, M&A
Former Dendreon CEO Gold Working on New Cancer Drug Startups
Xconomy
Friday, October 17, 2014 - 10:03am
tags:
Dendreon, Mitchell Gold, cancer
Amgen Files Lawsuit Against Sanofi And Regeneron For Patent Infringement
Yahoo
Friday, October 17, 2014 - 9:56am
tags:
Amgen, Sanofi, Regeneron, patents, alirocumab, monoclonal antibodies, evolocumab
Ackman: Lawyers have documents purported to show Allergan misled on Valeant
Yahoo/Reuters
Friday, October 17, 2014 - 9:54am
tags:
Bill Ackman, Valeant Pharmaceuticals, Allergan, M&A
Regeneron's Eylea works better vs Avastin and Lucentis in study
Yahoo/Reuters
Friday, October 17, 2014 - 9:50am
tags:
Regeneron, Eylea, Avastin, Lucentis, diabetic macular edema
Repros plummets as the FDA deals a blow to its low-T hopes
Fierce Biotech
Friday, October 17, 2014 - 9:27am
tags:
Repros Therapeutics, testosterone, FDA, Androxal
Adaptimmune's novel cancer treatment posts promising early results
Fierce Biotech
Friday, October 17, 2014 - 9:26am
tags:
Adaptimmune, GSK, cancer immunotherapy
AbbVie Kills Shire Merger, But Door Opens for Bristol-Myers Squibb?
TheStreet.com
Friday, October 17, 2014 - 9:15am
tags:
AbbVie, Shire, M&A, Bristol-Myers Squibb
FDA Announces Major Agency Reorganization, With Focus on Drug Quality
RAPS.org
Thursday, October 16, 2014 - 7:08pm
tags:
FDA, reorganization, quality
Stryker posts 3Q profit, results beat Wall Street forecasts
Yahoo/AP
Thursday, October 16, 2014 - 7:03pm
tags:
Stryker, earnings, devices
AbbVie’s Termination Fee Is the Third Largest Ever Paid
WSJ Online
Thursday, October 16, 2014 - 6:48pm
tags:
AbbVie, Shire, M&A
FDA strikes out again in Prevor drug-or-device case
Mass Device
Thursday, October 16, 2014 - 6:47pm
tags:
FDA, Prevor, devices
Sarepta +11.7% after hours on positive results for Ebola treatment
Seeking Alpha
Thursday, October 16, 2014 - 6:45pm
tags:
Sarepta Therapeutics, ebola virus, AVI-6002, AVI-6003

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.